Table 2.
Clinical Features of 65 iGAS Cases Identified From 26 Rural and Remote First Nations Communities in Northwestern Ontario Between 2009 and 2014
| Clinical Features | Number (%) |
|---|---|
| Culture source | |
| Blood | 49 (75.4) |
| Other sterile source | 15 (23.1) |
| Nonsterile source | 1 (1.5) |
| Clinical presentation | |
| Cellulitis | 36 (55.4) |
| Primary bacteremia | 17 (26.2) |
| Septic arthritis | 6 (9.2) |
| Pyomyositis | 2 (3.1) |
| Peritonitis | 2 (3.1) |
| Meningitis | 1 (1.5) |
| Pneumonia | 1 (1.5) |
| Disease severity | |
| Streptococcal toxic shock syndrome | 6 (9.2) |
| Necrotizing fasciitis | 6 (9.2) |
| Deceased | 4 (6.2) |
Abbreviations: iGAS, invasive group A streptococcal.